Vysnova now an approved subcontractor supporting US Navy Medicine’s global medical research and development efforts

Vysnova Partners, Inc. (Vysnova) received Government approval today and was added as an approved subcontractor on CAMRIS International, Inc. US Navy Medicine OMNIBUS-III Contract (under both the small and large business lots – contract numbers: W911QY11D0050 and W911QY11D0063.

Contracted by the U. S. Army ACC-APG, Natick Contracting Division on behalf of the U.S. Navy Medicine Research and Development (R&D), the Omnibus III contract provides personnel and process infrastructure that facilitates Navy Medicine’s mission to conduct R&D across its enterprise, including commands that the Navy reports to or supports (e.g., OASD-Health Affairs, JTF CapMed, etc.). In addition to providing personnel, materials, equipment, and facilities (non-construction (bonded), non-Government spaces), this contract addresses process infrastructure (such as basic university research, vaccine development, clinical trials, or FDA IND application processing).

The mission of Navy Medicine is to provide high quality, economical health care to beneficiaries in wartime and in peacetime. Highly trained Navy Medicine personnel deploy with Sailors and Marines worldwide, providing critical mission support aboard ship, in the air, and on the battlefield. Additionally, Navy Medicine’s military and civilian health care professionals are providing care for uniformed services’ family members and retirees at military treatment facilities around the globe.